Analysts at BTIG moved to the sidelines on online dating apps company Match Group (NASDAQ:MTCH) and lowered its investment ...

BTIG analyst Vincent Caintic maintained a Buy rating on Affirm Holdings (AFRM – Research Report) yesterday and set a price target of $81.00.

BTIG analyst Janine Stichter maintained a Buy rating on Lululemon Athletica (LULU – Research Report) today and set a price target of $470.00.

On Tuesday, BioNano Genomics Inc (BNGO) stock saw a decline, ending the day at $0.21 which represents a decrease of $-0.01 or -4.55% from the prior close of $0.22. The stock opened at $0.22 and ...

The economic fundamentals of Wednesday's inflation report will doubtless impact stocks. But before that let's have a chartist view from BTIG's technical guru Jonathan Krinsky. He notes that the S&P 50 ...

Strong order growth also contributed to BTIG’s upgrade to Buy from Neutral, with grocery delivery remaining one of the few ...

In recent trading, P3 Health Partners Inc (PIII) stock price has shown some volatility, fluctuating -13.35% over the last five trades a ...

BTIG Chief Market Technician Jonathan Krinsky thinks the market can “continue to make upside progress” into year-end and sees a new all-time high for the S&P 500 (SPX) above 6,100. However ...

Genius Sports Limited (NYSE: GENI) (“Genius Sports,” the “Company,” “we” or “our”) announced today the pricing of an underwritten public offering of 1 ...

BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of ...

BTIG's Krinsky noted that while equity markets in the first half of 2024 were fueled mostly by the surge in mega-cap names ...

BTIG analyst Thomas Shrader lowered the firm’s price target on Denali Therapeutics (DNLI) to $32 from $35 and keeps a Buy rating on the shares after the company announced topline data from the ...